Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Resmed Inc (RMD)

Resmed Inc (RMD)
235.78 +21.34 (+9.95%) 10:41 ET [NYSE]
235.69 x 18 236.06 x 100
Realtime by (Cboe BZX)
235.69 x 18 236.06 x 100
Realtime 228.64 +14.20 (+6.62%) 09:30 ET
Quote Overview for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
227.65
Day High
234.63
Open 233.19
Previous Close 214.44 214.44
Volume 570,827 570,827
Avg Vol 1,297,679 1,297,679
Stochastic %K 74.13% 74.13%
Weighted Alpha +6.09 +6.09
5-Day Change +21.51 (+10.17%) +21.51 (+10.17%)
52-Week Range 179.00 - 263.05 179.00 - 263.05
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,494,160
  • Shares Outstanding, K 146,867
  • Annual Sales, $ 4,685 M
  • Annual Income, $ 1,021 M
  • EBIT $ 1,605 M
  • EBITDA $ 1,821 M
  • 60-Month Beta 0.75
  • Price/Sales 6.71
  • Price/Cash Flow 23.20
  • Price/Book 5.99

Options Overview Details

View History
  • Implied Volatility 31.26% ( -15.08%)
  • Historical Volatility 40.77%
  • IV Percentile 45%
  • IV Rank 22.48%
  • IV High 63.20% on 08/01/24
  • IV Low 22.00% on 05/09/24
  • Put/Call Vol Ratio 0.74
  • Today's Volume 311
  • Volume Avg (30-Day) 837
  • Put/Call OI Ratio 2.12
  • Today's Open Interest 18,696
  • Open Int (30-Day) 21,182

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 2.45
  • Number of Estimates 7
  • High Estimate 2.56
  • Low Estimate 2.42
  • Prior Year 2.08
  • Growth Rate Est. (year over year) +17.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
199.92 +16.55%
on 04/07/25
Period Open: 222.91
234.63 -0.69%
on 04/24/25
+10.09 (+4.53%)
since 03/24/25
3-Month
199.92 +16.55%
on 04/07/25
Period Open: 250.51
263.05 -11.42%
on 01/30/25
-17.51 (-6.99%)
since 01/24/25
52-Week
179.00 +30.17%
on 04/25/24
Period Open: 183.78
263.05 -11.42%
on 01/30/25
+49.22 (+26.78%)
since 04/24/24

Most Recent Stories

More News
ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations

ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations

RMD : 235.78 (+9.95%)
ResMed: Fiscal Q3 Earnings Snapshot

ResMed: Fiscal Q3 Earnings Snapshot

RMD : 235.78 (+9.95%)
Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

RMD.AX : 36.080 (+8.51%)
RMD : 235.78 (+9.95%)
Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow

Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow

ABT : 129.66 (-0.14%)
RMD : 235.78 (+9.95%)
NEOG : 5.00 (+1.63%)
Resmed Names Salli Schwartz as Chief Investor Relations Officer

RMD.AX : 36.080 (+8.51%)
RMD : 235.78 (+9.95%)
Earnings Preview: What to Expect From ResMed’s Report

ResMed is set to release its fiscal third-quarter earnings this month, with analysts forecasting a lower-double-digit growth in profits.

XLV : 136.81 (+0.80%)
$SPX : 5,433.90 (+1.08%)
RMD : 235.78 (+9.95%)
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

RMD : 235.78 (+9.95%)
MASI : 161.07 (+1.99%)
PODD : 259.01 (+5.08%)
IRTC : 105.68 (+2.96%)
DXCM : 69.76 (+4.34%)
Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwlâ„¢, Now Available Across the US

RMD.AX : 36.080 (+8.51%)
RMD : 235.78 (+9.95%)
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

RMD : 235.78 (+9.95%)
MASI : 161.07 (+1.99%)
IRTC : 105.68 (+2.96%)
PODD : 259.01 (+5.08%)
DXCM : 69.76 (+4.34%)
Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

RMD.AX : 36.080 (+8.51%)
RMD : 235.78 (+9.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory...

See More

Key Turning Points

3rd Resistance Point 231.72
2nd Resistance Point 226.63
1st Resistance Point 220.53
Last Price 235.78
1st Support Level 209.34
2nd Support Level 204.25
3rd Support Level 198.15

See More

52-Week High 263.05
Last Price 235.78
Fibonacci 61.8% 230.94
Fibonacci 50% 221.02
Fibonacci 38.2% 211.11
52-Week Low 179.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective